Public Company News

L&C Bio's 'Re2O' Emerges as a Leading K-Medical Tour Procedure Within One Year of Launch

– Surging global demand drives rapid adoption across domestic and international medical sectors – SEONGNAM, South Korea, Dec. 2, 2025 /PRNewswire/ -- L&C Bio (KOSDAQ: 290650, Co-CEOsHwan-Chul Lee and Jae-Ho Lee), a leading company in human tissue–based regenerative medicine, announced that its p...

2025-12-02 22:00 1338

Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business -- To Accelerate U.S. Market

* Expert in sales and commercial strategy…Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai * To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions SEOUL, South...

2025-12-02 22:00 4736

Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities

SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity ...

2025-12-02 22:00 4885

Health In Tech Announces Voluntary Extension of Lock-Up Period

STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and  Board of Directors have voluntarily agreed to extend the lock-up r...

2025-12-02 21:00 3955

Origin Agritech's Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization

BEIJING, Dec. 2, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced that its pioneering corn haploid induction line Hi3 gene editing technology has been selected as one of the Top 10 Major Progre...

2025-12-02 20:00 3153

Recurrent Energy Secures Development Consent Order for the Tillbridge Solar and Battery Storage Project in the UK

The project combines 800 MW of solar PV and 500 MW / 1,000 MWh of battery energy storage, marking a major milestone in Recurrent Energy's UK growth strategy. KITCHENER, ON, Dec. 2, 2025 /PRNewswire/ -- Recurrent Energy , a subsidiary of Canadian Solar Inc. 

2025-12-02 20:00 3495

Four Seasons Education Reports First Half of Fiscal Year 2026 Unaudited Financial Results

SHANGHAI, Dec. 2, 2025 /PRNewswire/ -- Four Seasons Education (Cayman) Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a tourism and education-related service provider inChina, today announced its unaudited financial results for the first half of fiscal year 2026, endedAugust 31, 2...

2025-12-02 18:45 2998

GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper

* Officially recognized by WHO as a standard varicella vaccine strain alongside Oka * Interchangeability endorsed, enhancing global supply security YONGIN, South Korea, Dec. 2, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceutical company, today announced that its propriet...

2025-12-02 13:00 2556

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

BELLEVUE, Wash., Dec. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. This presentation will p...

2025-12-02 04:01 1746

E-Home Household Services Holdings Limited decided to acquire an AI access control system and smart community service company to expand its front-end industrial chain

FUZHOU, China, Dec. 1, 2025 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider inChina, announced today that following multiple rounds of negotiations and due diligence, it has decided to acquire Fuzhou Yunding ...

2025-12-01 22:00 4766

Luxshare Precision Embraces the Spirit of Thanksgiving with Year-Round Community Engagement in the U.S.

NEW YORK, Dec. 1, 2025 /PRNewswire/ -- As this year's Thanksgiving season, a season symbolizing gratitude, giving, and connection, comes to a close, Luxshare Precision, a leading enterprise in the electronic components industry, reaffirms its long-standing commitment to serving the communities wh...

2025-12-01 21:48 2712

Daesang to Participate in "FiE 2025" in Paris, Strengthening Global Ingredient Competitiveness

- To be held over three days from the 2nd to the 4th in Paris, France, with 1,550 companies and more than 24,000 visitors expected. - Specialty ingredients including amino acids and microalgae to be showcased, along with tasting sessions featuring dishes made with the natural seasoning ingredien...

2025-12-01 21:00 2389

YOULIFE ANNOUNCES CHANGES IN BOARD OF DIRECTORS AND MANAGEMENT

BEIJING, Dec. 1, 2025 /PRNewswire/ -- Youlife Group Inc. (Nasdaq: YOUL, "Youlife" or the "Company"), a leading blue-collar lifetime service provider in China, today announced changes in its board of directors (the "Board") and management. Changes in Board of Directors The Board has nominated and...

2025-12-01 20:00 2958

Canadian Solar to Resume Direct Oversight of U.S. Manufacturing and Operations

KITCHENER, ON, Dec. 1, 2025 /PRNewswire/ -- Canadian Solar Inc.  ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced a strategic initiative to resume direct oversight of its U.S. operations and to continue reshoring manufacturing toNorth America. The ...

2025-12-01 20:00 2807

MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators

SHANGHAI, Dec. 1, 2025 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, addresses the ten-day Order of Suspension of Trading in the securities of the Company entered by t...

2025-12-01 19:00 2819

CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT's Official Website

LISHUI, China, Dec. 1, 2025 /PRNewswire/ -- CN Energy Group. Inc. ("CNEY" or the "Company") (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. ("PATHENBOT"), has launched its robotics solutions platform and its official website (www.pat...

2025-12-01 18:55 4983

XPENG Announces Vehicle Delivery Results for November 2025

* 36,728 vehicles delivered in November, up 19% YoY GUANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868),a leading global AI mobility technology company, today announced its vehicle delivery results forNovember 2025. XPENG delivered 36,...

2025-12-01 17:28 5186

Zeekr Group Announces November 2025 Delivery Update

HANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forNovember 2025. In November, Zeekr Group delivered a total of 63,90...

2025-12-01 16:00 1882

BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough

* Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma * The company enables seamless Europe–China tech transfer and faster biologics development through an integrated, end-to-end...

2025-11-28 21:00 3547

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

* Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. * The collaboration includes precli...

2025-11-28 13:00 1986
1 ... 77787980818283 ... 765

Week's Top Stories